BLOG

NK Cell Therapy Infusion: Why IV and What to Expect on Treatment Day

7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

NK cell therapy is a form of cancer immunotherapy that utilizes the body’s own immune cells to target abnormal cells. After your natural killer (NK) cells are collected, activated, and expanded in number at a specialized facility, they are returned to your body. A common question patients have is about this final step: the infusion. This article explains the medical rationale behind using an intravenous (IV) drip for this process and provides a clear guide to what you can expect on the day of your treatment.

Why Are Cultured NK Cells Administered by IV Infusion?

The method of reintroducing the cultured NK cells into the body is crucial for the therapy’s approach. Administering the cells through an intravenous (IV) infusion is the standard method for several important medical reasons. This autologous cell therapy administration technique is designed to be both efficient and systemic.

  • Systemic Delivery: An IV infusion delivers the NK cells directly into the bloodstream. This allows them to circulate throughout the entire body, potentially reaching not only primary tumor sites but also microscopic cancer cells that may be circulating or have spread to other areas.
  • Maximum Bioavailability: By introducing the cells directly into the circulation, they bypass the digestive system and other biological barriers where they could be damaged or destroyed. This ensures that the maximum number of viable, highly active cells reaches the bloodstream to perform their function.
  • Controlled and Safe Administration: The IV drip allows healthcare professionals to control the rate of infusion precisely. This controlled process helps manage the introduction of a large number of cells into the body, allowing for careful monitoring and enhancing the safety of the procedure.

What to Expect: A Step-by-Step Guide to Your Treatment Day

Knowing what to expect during your NK cell therapy infusion can help alleviate anxiety and allow you to prepare. The process is generally straightforward and conducted in an outpatient setting, meaning no hospital stay is typically required.

1. Arrival and Preparation

On the day of your treatment, you will arrive at the clinic. A nurse or doctor will check your general condition, including your temperature, blood pressure, and pulse. You will be guided to a comfortable reclining chair or bed in a private room for the duration of the infusion.

2. The IV Infusion Process

A small IV catheter will be placed into a vein, usually in your arm. The bag containing your cultured NK cells, suspended in a solution, will then be connected to the IV line. The infusion itself is typically a slow drip that lasts approximately 30 to 60 minutes. During this time, you can relax, read, listen to music, or rest. Medical staff will be present to monitor you throughout the process.

3. Post-Infusion Monitoring and Departure

After the infusion is complete, the IV line will be removed. You will be asked to rest for a short period (e.g., 15-30 minutes) for observation to ensure you are feeling well. Once the medical team confirms your condition is stable, you are free to go home. Most people can resume their normal daily activities shortly after treatment, though it’s often recommended to avoid strenuous exercise or heavy alcohol consumption on the day of the infusion.

Important Considerations for NK Cell Therapy in Japan

When considering cancer immunotherapy in Japan, it’s essential to understand the context in which treatments like NK cell therapy are provided. This therapy is a form of regenerative medicine and is subject to specific regulations.

  • Regulatory Framework: In Japan, NK cell therapy is provided under the Act on the Safety of Regenerative Medicine. This means that treatment plans must be submitted to and approved by the Ministry of Health, Labour and Welfare, ensuring that cell processing and clinical application meet stringent safety standards.
  • Status as Private Medical Care: This treatment is not covered by Japanese public health insurance. It is considered an elective, private medical treatment (known as “jiyu-shinryo”). All costs associated with the therapy are the responsibility of the patient.
  • Potential Side Effects: Because the therapy uses your own cells, the risk of severe side effects is generally considered low. However, some individuals may experience temporary, mild symptoms such as a low-grade fever, fatigue, or headache on the day of or the day after the infusion. These are often signs that the immune system is responding.
  • The Need for a Medical Consultation: Eligibility for NK cell therapy, the expected number and frequency of treatments, and potential risks or side effects depend entirely on your individual health condition. A thorough consultation with a physician is necessary to determine if this therapy is an appropriate option for you.

Learn More at Grand Green Osaka Umekita Clinic

The decision to pursue any medical treatment requires careful consideration and access to reliable information. At Grand Green Osaka Umekita Clinic, located in the heart of Osaka, we provide consultations for patients interested in learning more about NK cell therapy. Our team is experienced in assisting international patients exploring medical tourism options in Japan.

We believe that a well-informed patient is better equipped to make decisions about their health. For more detailed information on our NK cell therapy program, including its features and the overall treatment flow, please visit our dedicated page.

Learn more about NK Cell Therapy here.

Summary: A Clearer Path to Understanding Your Treatment

The NK cell therapy infusion process is a carefully managed procedure designed to deliver activated immune cells throughout your body in an efficient manner. Understanding that the IV drip is a medically sound method for systemic delivery and knowing the straightforward steps of the treatment day can help demystify the experience. This treatment is intended to support the body’s natural defenses and should always be discussed with a qualified physician to see if it aligns with your overall health strategy. The final decision should be based on a professional medical diagnosis.

Learn more about NK Cell Therapy

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact